Q32 Bio Statistics
Share Statistics
Q32 Bio has 12.2M
shares outstanding. The number of shares has increased by 2.14%
in one year.
| Shares Outstanding | 12.2M |
| Shares Change (YoY) | 2.14% |
| Shares Change (QoQ) | 0.14% |
| Owned by Institutions (%) | 90.09% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,178 |
| FTD / Avg. Volume | 2.36% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.67 and the forward
PE ratio is -0.46.
Q32 Bio's PEG ratio is
-0.05.
| PE Ratio | -0.67 |
| Forward PE | -0.46 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 5.65 |
| P/FCF Ratio | -0.47 |
| PEG Ratio | -0.05 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Q32 Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97,
with a Debt / Equity ratio of 3.33.
| Current Ratio | 4.97 |
| Quick Ratio | 4.97 |
| Debt / Equity | 3.33 |
| Debt / EBITDA | -0.42 |
| Debt / FCF | -0.28 |
| Interest Coverage | -220.34 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,136,500 |
| Employee Count | 42 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 21K |
| Effective Tax Rate | -0.05% |
Stock Price Statistics
The stock price has increased by -94.37% in the
last 52 weeks. The beta is -0.02, so Q32 Bio's
price volatility has been lower than the market average.
| Beta | -0.02 |
| 52-Week Price Change | -94.37% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 21.43 |
| Relative Strength Index (RSI) | 39.45 |
| Average Volume (20 Days) | 219,415 |
Income Statement
| Revenue | n/a |
| Gross Profit | -487K |
| Operating Income | -66.1M |
| Net Income | -47.73M |
| EBITDA | -45.3M |
| EBIT | -45.79M |
| Earnings Per Share (EPS) | -5.12 |
Full Income StatementBalance Sheet
The company has 77.97M in cash and 18.9M in
debt, giving a net cash position of 59.06M.
| Cash & Cash Equivalents | 77.97M |
| Total Debt | 18.9M |
| Net Cash | 59.06M |
| Retained Earnings | -234.81M |
| Total Assets | 92.33M |
| Working Capital | 65.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -67.72M
and capital expenditures -75K, giving a free cash flow of -67.79M.
| Operating Cash Flow | -67.72M |
| Capital Expenditures | -75K |
| Free Cash Flow | -67.79M |
| FCF Per Share | -7.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
